Lisa A. Carey
Lisa A. Carey is a Distinguished Professor in Breast Cancer Research at UNC School of Medicine, Division Chief of Hematology and Oncology, and physician-in-chief of the N.C. Cancer Hospital, UNC Lineberger's clinical home. She studied at the Johns Hopkins School of Public Health, and was named co-chair of the Alliance National Cooperative Group Breast Committee in 2016. Provided by Wikipedia
Showing 1 - 7 results of 7 for search 'Lisa A. Carey', query time: 0.02s
Refine Results
-
1
Bridging the gap: ctDNA, genomics, and equity in breast cancer care by Julia Aronson, Manasa Bhatta, Lisa A. Carey, Kunal Jobanputra, Gaorav P. Gupta, Yara Abdou
Published 2025-08-01Get full text
Article -
2
-
3
Real-world breast cancer treatment patterns and guideline-concordant treatment completion among Malawian women by Jennifer Morgan, Shekinah Elmore, Takondwa Zuze, Lusayo Simwinga, Richard Nyasosela, Precious Makondi, Agnes Manda BSc, Chifundo Kajombo, Anthony Charles, Lisa A. Carey, Maurice Mulenga, Katherine Reeder-Hayes, Tamiwe Tomoka
Published 2025-03-01Get full text
Article -
4
B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancer by Siobhán O’Connor, Barbara Savoldo, Gianpietro Dotti, Simone Stucchi, Roberto Borea, Susana Garcia-Recio, Manuela Zingarelli, Patrick D Rädler, Elena Camerini, Caroline Marnata Pellegry, H Shelton Earp, Lisa A Carey, Charles M Perou
Published 2025-05-01Get full text
Article -
5
Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasets by Brooke M. Felsheim, Aranzazu Fernandez-Martinez, Cheng Fan, Adam D. Pfefferle, Michele C. Hayward, Katherine A. Hoadley, Naim U. Rashid, Sara M. Tolaney, George Somlo, Lisa A. Carey, William M. Sikov, Charles M. Perou
Published 2025-03-01Get full text
Article -
6
A latent class assessment of healthcare access factors and disparities in breast cancer care timeliness. by Matthew R Dunn, Didong Li, Marc A Emerson, Caroline A Thompson, Hazel B Nichols, Sarah C Van Alsten, Mya L Roberson, Stephanie B Wheeler, Lisa A Carey, Terry Hyslop, Jennifer Elston Lafata, Melissa A Troester
Published 2024-12-01Get full text
Article -
7
A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)Key Points: by Maeve A. Hennessy, Ashley Cimino-Mathews, Jodi M. Carter, Jennifer M. Kachergus, Yaohua Ma, Jeffrey P. Leal, Lilja B. Solnes, Vandana G. Abramson, Lisa A. Carey, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Christos Vaklavas, Ian Krop, Eric Winer, Rita Denbow, Vincente Valero, Antonio C. Wolff, Richard L. Wahl, Chiung-Yu Huang, Vered Stearns, E. Aubrey Thompson, Roisin M. Connolly
Published 2025-06-01Get full text
Article